Skip to content

Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults

Latinx Smokers: Evaluating Ethnic Microaggressions on Smoking Behavior and Relapse

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05490927
Enrollment
30
Registered
2022-08-08
Start date
2022-10-13
Completion date
2026-04-28
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Discrimination, Racial, Smoking

Keywords

Smoking, Hispanic, Latinx

Brief summary

The purpose of this study is to examine whether microaggressions relate to multimodal facets of smoking behavior, subjective withdrawal, and urge/craving. Additionally, the second aim is to examine whether smoking deprivation moderates the relation between microaggressions and multiple facets of smoking behavior, subjective withdrawal, and urge/craving.

Detailed description

This proposal will employ a novel multi-modal approach to evaluate the role of microaggressions in relation to smoking lapse and topography among a sample of Latinx smokers. Adult Latinx daily smokers will attend two counterbalanced experimental sessions - (1) smoking deprivation (16 hours of smoking abstinence) and (2) smoking as usual - during which microaggressions during the relapse analog task will be assessed.

Interventions

BEHAVIORALMicroaggression Recall and Relapse Analogue Task

Participants will engage in a microaggression recall task followed by the McKee Experimental Relapse Analogue Task

Sponsors

University of Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Being 18 years of age or older * Current regular (daily) cigarette smoking for \>= 1 year * Current smoking \>= 5 cig/day and biochemically confirmed via carbon monoxide (CO) analysis * Being self-identified as Hispanic or Latino * Able to provide written, informed consent * Endorsement of at least one microaggression experience over the past 6-months

Exclusion criteria

* Endorsement of current psychotic symptoms * Active suicidality * Currently pregnant

Design outcomes

Primary

MeasureTime frameDescription
Smoking BehaviorsDuring the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)Smoking behaviors will be operationally defined as smoking topography (e.g., puff behavior) measured via the Clinical Research Support System (CReSS; Plowshare Technologies, Borgwaldt KC, Inc., Virginia).
Subjective WithdrawalDuring the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)The 8-item Minnesota Withdrawal Scale will be used to assesses withdrawal severity. Each of the items are rated on a Likert-type scale ranging from 0 to 4. Items are summed to produce a total score with higher scores indicative of worse outcomes (possible range 0-32).
Urge/CravingDuring the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)Smoking urge/craving will be measured with the 10-item Questionnaire of Smoking Urges-Brief (QSU-B). Each of the items are rated on a Likert-type scale ranging from 1 to 7. Items are summed to create two subscale scores and a total score with higher scores indicative of worse outcomes (possible range 7-70).
Smoking Lapse BehaviorsDuring the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)Smoking Lapse Behaviors will be measured during the Relapse Analogue Task (RAT), during which participants are able to delay smoking for a small financial reward. For this task, Smoking Lapse Behaviors are conceptualized as two variables: (a) minutes in time of smoking delay (possible range -50 to +50) and (b) number of cigarettes smoked

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBrooke Y Kauffman, Ph.D.

University of Houston

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026